Cardiovascular Diseases Clinical Trial
To determine the combined effects of hostility, harassment, lipids, and oral contraceptive (0C) use on physiological responses in young and middle-aged premenopausal women.
BACKGROUND:
Preliminary findings already have shown that, in contrast to women with low scores on the
Cook and Medley Hostility (Ho) scale, women with high Ho scores exhibit greater
cardiovascular changes to harassment. Additional findings have suggested that oral
contraceptive (0C) use may also be associated with increased behaviorally-induced
physiological changes, especially in low Ho women. Similarly, higher levels of total serum
cholesterol (TSC) have been positively associated with greater stress-induced neurohormonal
changes in middle-aged men with high Ho scores.
DESIGN NARRATIVE:
Assessment of autonomic activity took place in the laboratory and during a 24 hour
ambulatory measurement period. Hostility was measured with the Cook and Medley Hostility
scale. The laboratory assessment helped to determine if high hostility women responded to
harassment with greater cardiovascular and neurohormonal changes than low hostility women,
and if this relationship was altered by 0C use, lipids, and age. The ambulatory assessment
of autonomic activity allowed an exploration of the responses of high and low hostility
subjects to daily-life stressors. Several hypothesis were explored: 1) Did harassment
produce neuroendocrine as well as cardiovascular hyperreactivity in young women, and did
this hyperreactivity generalize from laboratory to real-life? 2) Were the harassment-induced
cardiovascular and neuroendocrine changes in young women also present in middle-aged women?
3) To what extent did 0C use modulate the cardiovascular and neuroendocrine responses to
harassment in young women, and was 0C use also altering the hostility--related associations
between lipids and reactivity? 4) Were the differential lipid-reactivity associations
observed in middle-aged men as a function of high and low hostility scores present in women,
and, if so, were they modulated by age?
The study completion date listed in this record was obtained from the "End Date" entered in
the Protocol Registration and Results System (PRS) record.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|